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Abstract
Eugenia uniflora, used ethnomedically in some tropical countries as an anti-infective, has shown anti-malarial and anti-
trypanocidal activities. Therefore using bioactivity guided fractionation, anti-trichomonal activity of E. uniflora leaf was
investigated. Anti-trichomonal activities of leaf methanol extract and its fractions against Trichomonas gallinae as well as their
cytotoxicities using an in vitro haemaglutination assay were determined. Anti-trichomonacidal activities of the extract improved
on purification up to a stage. Subfractions E2-5 had LC50 and LC90 values of 4.77 - 5.28, 18.49 - 25.00 and 4.53 - 5.18, 18.32 -
19.07 μg/ml at 24 and 48 hrs, respectively that were better than those of metronidazole. Further purification of E2-5 led to loss of
activity suggesting that the active components were probably working synergistically and additively. Demonstration of low
haemaglutination titre values of 0.00 – 5.33 by methanolic extract and its partition fractions suggested their low toxicity profile.
The established safety of the leaf indicated that its anti-trichomonal activity was not due to non-specific cytotoxicity, hence could
be used in ethnomedicine as an anti-trichomonal agent.
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Introduction
Trichomoniasis affects humans and animals causing heavy economic losses in poultry and livestock due to high
mortality in birds, and morbidity in man (Adebajo et al., 2009). In Nigeria, the prevalence depends on age, profession and
location of the citizens (Omisore et al., 2005). Its chemotherapy has been undermined by resistance, variable efficacy between
strains or species, toxicity, need for parenteral administration and requirement for long courses of administration (Narcisi and
Secor, 1996; Munoz et al., 1998; Camacho et al., 2000, 2003). Since the safe drugs available are limited, investigation of plants
with possible anti-trichomonal activities is obligatory (Camacho et al., 2000, 2003; Adebajo et al., 2004, 2006, 2007, 2009;
Omisore et al., 2005; Mahdi et al., 2006).
Eugenia uniflora L. (Myrtaceae), native to Surinam, Guyana, Southern Brazil, Uruguay, is widely distributed in other
South American countries. It is cultivated as an ornamental hedge and for its edible fruits in tropical and subtropical countries,
including Nigeria (Dalziel and Hutchinson, 1966; Adebajo et al., 1989a). Mono- and sesqui-terpenoids from leaf and fruit
essential oils (Weyerstahl et al., 1988; Onayade et al., 1999); triterpenoids and their acetates (Rücker et al., 1977), tannins
(Consolini and Sarubbio, 2002), macrocyclic hydrolysable tannin dimers (Lee et al., 1997), xanthine oxidase inhibitory
flavonoids (Schmeda-Hirschmann et al., 1987) and uniflorines A and B (Matsumura et al., 2000) have been reported.
Ethnomedically, various extracts of the whole plant or leaves are used in several countries as remedy for headaches, influenza,
bronchitis, chest cold, cough, gout, sore throat, hypertension, hepatic disease, fever, rheumatism, stomach diseases and other
gastro-intestinal disorders, as a diuretic, for its astringent and insect repelling properties, or drunk as a tea shortly before child
birth (Weyerstahl et al., 1988; Adebajo et al., 1989a,b; Arai et al., 1999; Consolini and Sarubbio, 2002). It is also used to
stimulate menstrual flow (Sussman, 1980), against obesity and diabetes (Arai et al., 1999); its volatile oil as a digestive,
eupeptical and carminative remedy and in Nigeria, a hot water extract of the fresh leaf and unripe fruit is used as antipyretic,
febrifuge and antimalarial drug (Adebajo et al., 1989a, b).
Anti-parasitic activities such as anti-trypanocidal and anti-malarial (Agbedahunsi and Aladesanmi, 1993; Adewunmi et
al., 2001), other biological and pharmacological activities have been reported for the plant (Adebajo et al., 1989a; Schapoval et
al., 1994; Gbolade et al., 1996; Arai et al., 1999; Matsumura et al., 2000; Consolini and Sarubbio, 2002). Anti-trichomonal
activity of E. uniflora has not been reported. We therefore investigated the anti-trichomonal effects of methanolic leaf extract and
fractions of E. uniflora, using activity-directed fractionation and Trichomonas gallinae.
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Materials and methods
Plant material, extraction and purification
Eugenia uniflora leaves were collected in January 2005 from the shrubs earlier identified and voucher specimen FHI
102196 was deposited at the Forestry Research Institute of Nigeria, Ibadan, Nigeria (Adebajo et al., 1989a,b). A 5.0 kg of
powdered leaf was cold extracted with 5 litres of methanol (MeOH) for 3 days, the extract was filtered and concentrated in-
vacuo. This process was repeated four times and the combined extracts were further concentrated in vacuo to give a 541 g
methanolic extract (A, 10.82 % w/w yield), which was subjected to anti-trichomonal activity testing.
TLC analyses of methanolic extract, its partition and chromatographic fractions
The Thin Layer Chromatographic (TLC) analyses of the extract (A) was done using the solvent systems: 1: n-hexane-
CHCl3 1:1; 2: CHCl3 100%; 3: CHCl3-MeOH 9:1; 4: CHCl3-MeOH 7:3; 5: CHCl3-EtOAc-MeOH 5:2:3 and 6: CHCl3-MeOH-
H2O 5:3:2 and the spots were detected by UV (366 nm) and 10 % H2SO4 followed by heating. Partition, vaccum liquid (VLC)
and column chromatographic (CC) fractions were bulked into (B1-5), C1-5, D1-9, E1-13, F1-12, G1-7 and H1-7 based on similarity of
their chromatograms and using solvent systems 1 – 6.
Partition fractions (B1-5)
520 g methanolic extract (A) was suspended in 150 ml water (H2O), solvent partitioned (5 x 250 ml) and concentrated
in vacuo to give n-hexane (B1, 75 g), CHCl3 (B2, 133 g), EtOAc (B3, 65 g), BuOH (B4, 123.4 g) and aqueous (B5, 106 g) partition
fractions that were tested for anti-trichomonal activity.
Vacuum liquid chromatographic (VLC) fractions C1–C5
The most active B2 and B3 fractions were combined (183 g) and subjected to VLC, gradiently eluted with petroleum
ether, CHCl3, MeOH. The fractions, based on TLC similarities in solvent systems (1–3, 5), were bulked into C1 (petroleum ether
100 %, 5 x 200 ml, 32.0 g), C2 (pet. ether-CHCl3 1:1, 5 x 200 ml, 48.2 g) and C3 – C5.
VLC subfractions D1-9 and E1-13
Most active C1 and C2 were separately subjected to VLC. VLC of C1 (31.0 g) was repeated with a more gradient
elution of petroleum ether, CHCl3, MeOH and similarly bulked to give D1 - D6, D7 (CHCl3 100 %, 450 ml, 1.6 g) and D8 - D9. A
40.9 g of C2 was similarly treated to obtain E1, E2 (pet. ether–CHCl3 45:55, 450 ml, 1.9 g), E3 (pet. ether-CHCl3 45:55, 600 ml,
2.3 g), E4 (pet. ether-CHCl3 45:55, 600 ml; pet. ether-CHCl3 30:70, 700 ml, 7.1 g), E5 (CHCl3 100 %, 900 ml, 2.7 g) and E6 - E13.
CC subfractions F1-12
The most active D7 and E2–5 showed great similar TLC characteristics and due to their low yields, they were combined
and further purified using CC to obtain CC subfractions F1 - F12.
Anti-trichomonal bioassay
Trichomonas gallinae were collected from local Pigeon Columba lavia (Anth) Columbidea by inserting a sterile cotton
swab into its crop (Narcisi and Secor, 1996; Omisore et al., 2005). The swab was dipped into a test tube of normal saline,
distributed into test tubes of Ringers-egg-serum culture for enteric protozoan, prepared according to the modified method of
Levine (1961) and incubated at 37o C for growth. Stock solutions of Metronidazole (positive control drug), the extract, fractions
and subfractions obtained above, in DMSO at the concentration of 20 mg/ml were made. Their serial dilutions to 0.00, 3.906,
7.8125, 15.625, 31.25, 62.5, 125, 250, 500 and 1,000 µg/ml with the fluid nutrient solution were used as the test agents. A 50 µl
of each test agent and 150 µl of the nutrient solution were pipetted into the 96-microwells and incubated in the steam incubator at
37o C for 24 and 48 hr; 50 μL of DMSO served as a negative control. The number of surviving trichomonads per millilitre in each 
well for 0, 24 and 48 hr were counted using the microscope. The experiments were replicated nine times (Adebajo et al., 2009).
The lethal doses (LC50 and LC90) at these times were determined using the Microsoft Excel 2008 and subjected to statistical
analysis using ANNOVA followed by Dunnett post-hoc test. P < 0.05 was considered as significant.
Cytotoxicity Assay
Cytotoxicity of the extract and its fractions were determined by haemagglutination activity using formaldehyde fixed
bovine erythrocytes. 100 µL of phosphate buffer saline (PBS) was pipetted into 96-well microtitre plates. The first row was
without the extract/fractions and used as control. The extract and fractions (100 µL) were added into the first well of the second
row, and two-fold serial dilutions were made until the last well in row three. Thereafter, 50 µL of bovine red blood cell was
added to all the wells and incubated for one hour. The presence of buttons at the centre of the well indicated no agglutination and
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the heamagglutination titre values of the extract/fractions were read as the reciprocal of the last dilution showing agglutination
(Peumans, et al, 1982; Sadique et al., 1989; Wang et al, 1995).
Results
The anti-trichomonal activities of E. uniflora leaf methanolic extract (A), its five partition fractions (B1-5) and the VLC
subfractions (C1-5) of the most active B2 and B3 fractions were given in Table 1. Those of the subfractions D1-9, E1-13 and F1-12
were presented in Tables 2 – 4, respectively. Haemagglutination values, as indices of cytotoxicities of the leaf extract and
partition fractions, were also given in Table 5.
Discussion
Leaf methanolic extract of E. uniflora was less active than Metronidazole (Table 1). The CHCl3 and EtOAc partition
fractions were the most active and had lower LC50 and LC90 values at 48 than 24 hrs indicating, that their activities were
trichomonacidal. Hence, the main active constituents were likely to be moderately non-polar to mediumly polar in nature. N-
hexane fraction had higher LC50 and LC90 values at 48 than 24 hrs, indicating that the trichomonads were able to recover after 24
hrs and the activity was trichomonastatic (Table 1). Similar anti-parasitic activities of antimalarial (Agbedahunsi and
Aladesanmi, 1993) and anti-trypanocidal (Adewunmi et al., 2001) have been reported for the leaf extract and fractions. However,
anti-trichomonal activity of the plant is hereby reported for the first time.
Table 1: Anti-trichomonal activities of Eugenia uniflora leaf methanolic extract, its partition and VLC fractions.
24 hrs 48 hrsExtract/Fractions/
Drug LC50 (µg/ml) LC90 (µg/ml) LC50 (µg/ml) LC90 (µg/ml)
MeOH (A) 61.70±1.65† 386.84±4.32† 55.15± 2.17† 302.93±9.54†
n-Hexane (B1) 40.00±2.24*,† 271.10±5.72*,† 70.52± 3.41† 551.69±2.37*,†
CHCl3 (B2) 27.60± 3.76* 126.95±2.82*,† 18.67± 3.29* 68.82± 5.41*
EtOAc (B3) 41.51± 4.48† 194.79±7.57*,† 24.18± 1.37* 86.39±2.04*
BuOH (B4) 58.62± 2.56† 353.79±10.75† 52.31±3.71† 427.39±9.65*,†
Aqueous (B5) 103.19±0.96*,† 704.65±2.66*,† 59.10± 8.34† 592.06± 2.01*,†
C1 35.08±2.89* 238.50± 9.17*,† 18.05± 5.09* 106.90± 5.21*,†
C2 36.43± 2.73*,† 265.34± 9.43*,† 32.69± 4.66*,† 156.95± 5.68*
C3 222.83± 9.26* 1063.57±5.81*,† 40.88± 4.95† 263.50± 4.76†
C4 75.10± 4.64*,† 747.77± 3.14*,† 206.08± 9.86* 1010.40±10.56*,†
C5 125.69±1.30*,† 1274.49±4.89*,† 27.12± 7.00 168.75±11.11*
Metronidazole 13.67± 0.87* 42.86± 2.60* 14.04± 5.85* 61.37±8.69*
A: Methanolic extract; B1: N-hexane, B2: Chloroform, B3: Ethylacetate, B4: Butanol, B5: Aqueous partition fractions;
C1–5: VLC subfractions of the combined most active partition fractions B2 and B3. N = 9; p < 0.05; *: LC50 and LC90 vs
MeOH, †: LC50 and LC90 vs metronidazole. LC50 and LC90: Values ± SEM.
C1 and C2 with activities comparable to their mother fractions B2-3, were the most active VLC fractions obtained by
purification of the combined fractions B2-3. They were however less active than metronidazole (Table 1) and since their TLC
characteristics were slightly different, they were separately further purified. Subfractions D1, D3, D5 and D7 gave similar activity
at 24 and 48 hr. Trichomonacidal activity of D7 was better than that of C1, showing that it should contain more of the active
compounds (Tables 1, 2). D7 with LC50 values of 13.81 and 12.38 µg/ml at 24 and 48 hr, respectively was as potent as
metronidazole (Table 2). Similarly, E2-E5 had higher activities and lower LC50 and LC90 values than C2 and metronidazole
(Tables 1, 3).
Up to this stage, purification led to better activities than the mother fractions, suggesting that chemical compounds in
the extract are responsible for its anti-trichomocidal activity. Hence, the most active D7 and E2-E5 fractions were combined and
subjected to CC. The resulting fractions F1-12 had higher LC50 and LC90 values than D7 and E2-E5 subfractions (Tables 2 - 4),
indicating that further purification did not result in improved activity. Only F6 and F7 had activities that were comparable to that
of metronidazole and D7 (Table 4).
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Table 2: Anti-trichomonal activities of subfractions D1-9.
24 hrs 48 hrsSubfractions /
Drug LC50 (µg/ml) LC90 (µg/ml) LC50 (µg/ml) LC90 (µg/ml)
C1 35.08±2.89† 238.50± 9.17† 32.69± 4.66† 106.90± 5.21†
D1 34.91 ± 3.14† 246.76±14.86† 49.11± 1.98† 218.26±13.16*,†
D2 61.99± 2.11*,† 300.82± 16.88† 39.90± 1.77† 130.90±10.69†
D3 37.83± 1.54† 188.24± 12.36*,† 34.68±3.05*,† 131.35±10.89†
D4 26.76± 0.99† 204.09±13.25† 56.23± 2.32† 235.11±7.60*,†
D5 33.34± 1.46† 149.20±17.74*,† 44.82± 3.09† 181.85± 7.36†
D6 25.95± 0.78† 112.01±11.56*,† 46.56±4.26† 135.10± 5.33†
D7 13.81± 1.27* 41.26± 8.10*,† 12.38±4.34* 37.71± 2.79*,†
D8 30.40± 3.30† 127.47± 8.77*,† 22.03± 0.30* 72.21± 2.97*
D9 55.24±0.30*,† 318.27±19.95*,† 31.97±1.95† 118.22±4.99†
Metronidazole 13.67± 0.90* 42.86± 0.87* 14.04± 5.85* 61.37±8.69*
D1–9: VLC subfractions of an active VLC fraction C1. N = 9; p < 0.05; *: LC50 and LC90 vs C1; †: LC50 and LC90 vs
metronidazole. LC50 and LC90: Values ± SEM.
Table 3: Anti-trichomonal activities of subfractions E1-13.
24 hrs 48 hrsSubfractions/
Drug
LC50 (µg/ml) LC90 (µg/ml) LC50 (µg/ml) LC90 (µg/ml)
C2 36.43± 2.73*,† 265.34± 9.43† 18.05± 5.09 156.95± 5.68†
E1 131.71 ± 1.38*,† 2363.73 ± 9.33*,† 133.37 ±2.04*,† 2124.73 ±12.72*,†
E2 4.95 ± 0.78*,† 20.93 ± 1.92* 3.61 ± 2.54*,† 18.69 ± 2.96*,†
E3 5.61± 1.30*,† 20.72 ± 3.29* 3.24 ± 0.63*,† 16.28 ± 2.03*,†
E4 4.77 ± 0.83*,† 18.49 ± 2.94* 4.53 ± 1.23*,† 18.38 ± 3.70*,†
E5 7.28 ± 0.87*,† 25.00 ± 2.95* 4.95 ± 0.81*,† 19.07 ± 2.20*,†
E6 40.28 ± 0.85† 168.04 ± 8.27*,† 22.53 ± 1.38† 157.95 ± 6.31†
E7 32.78 ± 1.28† 182.67 ± 4.63*,† 33.38 ± 0.85*,† 207.89 ± 7.64†
E8 84.27 ± 0.75*,† 935.05 ± 11.11*,† 58.11± 0.99*,† 565.03 ± 9.30*,†
E9 61.55 ± 0.93*,† 828.32 ± 4.06*,† 63.40 ± 0.66*,† 551.64 ± 7.22*,†
E10 60.73 ± 0.79*,† 694.85 ± 5.53*,† 58.87 ± 1.45*,† 390.53 ± 8.14*,†
E11 69.15 ± 0.09*,† 725.31 ± 9.33*,† 78.63 ± 0.64*,† 639.83 ± 3.57*,†
E12 69.28 ± 1.22*,† 507.34 ± 3.27*,† 89.16 ± 0.44*,† 680.21 ± 6.99*,†
E13 70.46 ± 0.37*,† 735.55 ± 9.27*,† 124.46 ± 0.87*,† 959.10 ± 6.63*,†
Metronidazole 13.67 ± 0.03* 42.86 ± 0.87* 14.04 ± 1.95 61.37 ± 8.69*
E1–13: VLC subfractions of an active VLC fraction C2. N = 9; p < 0.05; *: LC50 and LC90 vs C2; †: LC50 and LC90 vs
metronidazole. LC50 and LC90: Values ± SEM.
The decreased activity as purification progressed showed that the active trichomocidal components of the leaf were
probably working synergistically. Comparing the TLC characteristics of the various active fraction/subfractions showed that
spots with Rf 0.12 and 0.06 (silica gel, 100% CHCl3) fluorescencing blue under UV and red colour with H2SO4 were common to
all of them, suggesting that the active compounds are likely to be moderately polar. Since flavonoids and phenolics have been
detected during phytochemical screening of the combined active B2 and B3 fractions of E. uniflora leaf (Adebajo et al., 1989a)
and xanthine oxidase inhibitory flavonoids have been isolated from equivalent leaf fraction (Schmeda-Hirschmann et al., 1987),
the active constituents are therefore suspected to be flavonoids. Due to this demonstrated synergism of the constituents of this
plant, further purification was deemed unnecessary.
Metronidazole is the drug of choice in the treatment of human and animal trichomoniasis all over the world. Side
effects of metronidazole include allergic reaction, nausea, diarrhoea, dryness of the mouth, leucopoenia and intolerance to
alcohol. It is also not recommended during the first trimester of pregnancy or breast feeding while increasing resistance against
metronidazole is common (Narcisi and Secor, 1996; Munoz et al., 1998). Acceptable drugs, particularly from plant sources,
against trichomoniasis are therefore of a high priority (Adebajo et al., 2006, 2007; Mahdi et al., 2006). Hence, any of the purified
fractions of D7, E2–5, F6 and F7 that were more active or comparable in activity to metronidazole, may be relevant as a readily
available alternative drug for the treatment of animal and human trichomoniasis.
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Table 4: Anti-trichomonal activities of subfractions F1-12.
24 hrs 48 hrsCC Subfractions
LC50 (µg/ml) LC90 (µg/ml) LC50 (µg/ml) LC90 (µg/ml)
D7 13.81± 1.27 41.26± 8.10 12.38±4.34 37.71± 2.79†
F1 100.21± 0.83*,† 1347.09±5.14*,† 179.59 ±1.04*,† 4692.0 ± 6.19*,†
F2 26.63 ± 0.71*,† 78.43 ± 8.83*,† 23.56 ± 0.99*,† 128.14±11.24*,†
F3 22.28 ± 0.64*,† 91.00 ± 3.94*,† 24.76 ± 0.72*,† 96.63 ± 5.33*,†
F4 23.96 ± 0.70*,† 117.04 ±4.18*,† 19.46 ± 0.72*,† 99.32 ±7.26*,†
F5 21.30 ± 1.09*,† 97.23 ± 6.13*,† 21.09 ± 0.52*,† 98.49 ± 2.64*,†
F6 18.49 ± 0.89*,† 69.85 ± 5.75*,† 16.88 ± 0.35 64.71 ± 6.42*
F7 16.79 ± 0.92 60.60 ± 4.11 14.17 ± 0.95 63.59 ± 2.63*
F8 26.41 ± 0.59*,† 138.84 ± 6.68*,† 20.80 ± 0.73*,† 104.57 ± 6.26*,†
F9 47.21 ± 0.83*,† 203.96 ± 7.91*,† 42.95 ± 0.78*,† 432.16 ± 2.14*,†
F10 36.29 ± 1.02*,† 177.24 ± 7.32*,† 60.34 ± 0.70*,† 571.35 ± 5.49*,†
F11 62.13 ± 0.70*,† 382.18 ± 8.47*,† 33.00 ± 0.62*,† 198.15 ± 7.59*,†
F12 257.80 ±0.89*,† 11960.92±8.12*,† 137.74 ±1.07*,† 2114.56±5.86*,†
Metronidazole 13.67± 0.30 42.86 ± 0.87 14.04 ± 1.95 61.37 ± 8.69*
F1–12: CC subfractions of the combined most active VLC fractions D7 and E2-5. N = 9; p < 0.05; *: LC50 and LC90 vs D7; †:
LC50 and LC90 vs metronidazole. LC50 and LC90: Values ± SEM.
The MeOH extracts of Murrya koenigii leaf and stem were reported less active than metronidazole, and its carbazole
constituents, especially girinimbine, girinimbilol and girinimbiyl acetate with comparable activity with metronidazole, were the
active compounds (Adebajo et al., 2004, 2006). MeOH extracts of the furocoumarin-producing M. koenigii seeds and pericarp
also showed comparable anti-trichomonal activities with metronidazole. Their active constituents were identified as the
furocoumarins isoimperatorin, isogosferol and indicolatone. Since none of the furocoumarins isolated gave a significantly higher
activity than the MeOH extracts of the seeds or pericarps, it has been suggested that active compounds were probably working
synergistically (Adebajo et al 2007). Antitrichomal activities of extracts of Dorstenia barteri and D. convexa (Omisore et al.,
2005) and Harungana madagascariensis have also been reported (Iwalewa et al., 2008). Imperatorin and 3-formylcarbazole that
had better activities than the dichloromethane extract were the most active compounds of Clausena lansium stem bark (Adebajo
et al., 2009).




MeOH (A) 0.26 ± 0.05 5.33 ± 2.93
n-Hexane (B1) 3.00 ± 0.00 0.33 ± 0.00
CHCl3 (B2) 0.23 ± 0.05 4.67 ± 0.67
EtOAc (B3) 0.28 ± 0.05 4.00 ± 0.77
BuOH (B4) 0.47 ± 0.09 2.34 ± 0.34
Aqueous (B5) 0.53 ± 0.02 1.89 ± 2.17
A: Methanol extract; B1: N-hexane, B2: Chloroform, B3: Ethylacetate, B4: Butanol, B5: Aqueous partition fractions.
LC50 and LC90: Values ± SEM.
The E. uniflora leaf extract and partition fractions showed low haemaglutination titre values (Table 5), suggesting their
low toxicity profile and safe internal use in medicine (Sadique et al., 1989). Since the plant is therefore considered safe, its anti-
trichomonal activity was not due to non-specific cytotoxicity. A hydro-alcoholic extract of the leaves, when administered orally
to mice in doses up to 4,200 mg/kg, lacked acute or subacute toxicity. This extract also gave an LD50 of 220 mg/kg when given
i.p. to mice. Based on these results, the plant was declared safe for internal use in treating gout by herbalists in Paraguay
(Schmeda-Hirschmann et al., 1987). Our present results of no toxicity therefore agreed closely with the earlier report (Schmeda-
Hirschmann et al., 1987).
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Conclusion
Anti-trichomonal activity directed purification of E. uniflora leaf extract gave subfractions D7, E2– 5, F6 and F7 with
higher or comparable activity to that of metronidazole. Since the folkloric use of the plant as a safe anti-parasitic agent was
confirmed, E. uniflora leaf could be used in ethnomedicine as an anti-trichomonal agent and its chemotherapeutic potential may
need to be further exploited.
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